ProPhase Labs (PRPH) Common Equity (2016 - 2025)
Historic Common Equity for ProPhase Labs (PRPH) over the last 16 years, with Q3 2025 value amounting to $6.9 million.
- ProPhase Labs' Common Equity fell 8200.44% to $6.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.9 million, marking a year-over-year decrease of 8200.44%. This contributed to the annual value of $7.4 million for FY2024, which is 8511.03% down from last year.
- As of Q3 2025, ProPhase Labs' Common Equity stood at $6.9 million, which was down 8200.44% from $11.4 million recorded in Q2 2025.
- In the past 5 years, ProPhase Labs' Common Equity ranged from a high of $68.2 million in Q2 2022 and a low of $6.9 million during Q3 2025
- Its 5-year average for Common Equity is $45.6 million, with a median of $49.4 million in 2023.
- As far as peak fluctuations go, ProPhase Labs' Common Equity surged by 45539.98% in 2021, and later tumbled by 8511.03% in 2024.
- ProPhase Labs' Common Equity (Quarter) stood at $58.6 million in 2021, then increased by 8.53% to $63.6 million in 2022, then decreased by 22.39% to $49.4 million in 2023, then plummeted by 85.11% to $7.4 million in 2024, then dropped by 6.69% to $6.9 million in 2025.
- Its Common Equity was $6.9 million in Q3 2025, compared to $11.4 million in Q2 2025 and $15.1 million in Q1 2025.